http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-6220932-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
filingDate 2009-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82fdd1f1af8cf3e928422da72ed33f00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e41238487ec68e06212f6669ec8f72a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6176c527a15914b00d05995e8442afc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2303318c88e7c9877430fc798a05c48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0b29a86afe46f98a149f24339a9bae5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6ba3514dec966a8051809b1ea9675ab
publicationDate 2010-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-6220932-A2
titleOfInvention MODULATORS OF CANNBINOIDS HEXAHIDRO-CICLOOCTIL PIRAZOL
abstract 1. A compound having the structure according to formula (I): or a salt, isomer, prodrug, metabolite or polymorph thereof where the dotted lines between positions 2-3 and positions 3-9a in Formula (I) represents sites for each of the two double bonds present when X1R1 is present; the dotted lines between positions 3-3a and positions 9a-1 in formula (I) represent sites for each of the two double bonds present when X2R2 is present; the dotted line between position 9 and X4R4 in formula (I) represents the site for a double bond; X1 is absent or is lower alkylene; X2 is absent or is lower alkylene; wherein only one of X1R2 and X2R2 is present; X3 is absent, lower alkylene, lower alkylidene or -NH-; when the dotted line between position 9 and X4R4 is absent, X4 is absent or is lower alkylene; when the dotted line between position 9 and X4R4 is present, X4 is absent; X5 is absent or is lower alkylene; R1 is selected from hydrogen, alkyl (optionally substituted in one or more positions by halogen, hydroxy or lower alkoxy), lower alkyl sulfonyl, aryl, C3-C12 cycloalkyl or heterocyclyl, wherein aryl, C3-C12 cycloalkyl or heterocyclyl each is optionally substituted in one or more positions by halogen, aminosulfonyl, lower alkyl-aminosulfonyl, alkyl (optionally substituted in one or more positions by halogen, hydroxy or lower alkoxy) hydroxy or alkoxy (optionally substituted in one or more positions by halogen or hydroxy); R2 is selected from hydrogen, alkyl (optionally substituted in one or more positions by halogen, hydroxy or lower alkoxy), lower alkyl sulfonyl, aryl, C3-C12 cycloalkyl or heterocyclyl, wherein aryl, C3-C12 cycloalkyl or heterocyclyl each is optionally substituted in one or more positions by halogen, aminosulfonyl, lower alkyl-aminosulfonyl, alkyl (optionally substituted in one or more positions by halogen, hydroxy or lower alkoxy), hydroxy or alkoxy (optionally substituted in one or more positions by halogen or hydroxy); R3 is -C (O) -Z1 (R6), -SO2-NR7-Z2 (R8) or -C (O) -NR9-Z3 (R10); when the dotted line between position 9 and X4R4 is absent, ...
priorityDate 2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457584123

Total number of triples: 51.